Try our Advanced Search for more refined results
Life Sciences - February, 2025
275 articles
- Align Tech Deal Directs Buyers To A Monopolist, Judge Says
- J&J Talc Spinoff Wraps Two-Week Chapter 11 Trial
- Fenwick Adds Longtime Startup Attorney To Insurtech Group
- Sterilization Plant Head 'Shocked' By EPA Cancer Risk Report
- Trump Can't 'Erase' Trans People Via Order, Wash. Judge Says
- Group Blasts Judge's Call For Women In Contraception MDL
- Robotic Surgery Co. Appealing Tossed Intuitive Antitrust Case
- Dartmouth Wants Fed. Circ. To Ax Fees After Vitamin IP Loss
- Drug Kickback Ruling Will Make FCA Liability Harder To Prove
- Aimmune Shareholders' $27.5M Deal Over Sale To Nestle OK'd
- Bioventus Hit With Del. Derivative Suit After NC Class Deal
- NFL Alums Say Vaccine Fund Misuse Claims Should Fail
- Assessing PE Risk After Mass. False Claims Act Amendments
- China Signals Retaliation Following Extra 10% US Tariff
- Taxation With Representation: Gibson Dunn, Skadden
- Goodwin, White & Case Build BridgeBio's $949M SPAC Deal
- Don't Fault Sterilization Co. For What It Didn't Know, Jury Told
- Liquidia Challenge To UTC's Tyvaso Exclusivity Fails
- CooperSurgical Says Unique IVF Claims Require Separate Trials
- What Trump Actions Mean For Federal Research Funding
- CVS Freed From Hospital's Suit Over Drug Pricing Program
- $40M Deal OK'd For Suit Over Emergent Vax Flub
- OpenEvidence Says Rival's Attack Targeted Its AI 'Blueprint'
- Lead Testing Co. Director To Admit False Statements
- DOJ Says It Will No Longer Defend DEA Admin Judges
- Ex-Worker Says Manufacturer Fails To Pay For Off-Clock Work
- 4th Circ. Rips 'Shaky At Best' Drug Price-Fixing Class Action
- McCarter & English Wants $3.8M, Ex-Client Wants New Trial
- Lenders Can't Claim Ex-Mylan VP's $4M Insider Trade Penalty
- Medical Device Co. Inks €760M Deal, Unveils Separation Plans
- How Courts Can Filter Nonmeritorious Claims In Mass Torts
- Anthropic Could Hit $62B Valuation, And More Deal Rumors
- Racing Corvettes Makes Me A Better Lawyer
- Merck, Glenmark Trim United Healthcare's Zetia Antitrust Suit
- Trump Orders Fed Agencies To Plan For Large Layoffs
- Simpson Thacher Adds Partner From Wilson Sonsini
- Planned Parenthood Immune From FCA Suit, 5th Circ. Says
- GOP-Led House Panel Pushes Easier Rules On Capital Raising
- CBD Co. Sues Rivals Over Topical Treatment Patents
- Attorneys Must Act Now To Protect Judicial Independence
- CVS Ordered To Comply With FTC's PBM Subpoena
- Walgreens Inks $595M Deal To End COVID-19 Testing Suit
- Pa. Biotech Co. Can't Escape $4M Trade Secrets Award
- Trump Says Transgender Order Shields Kids From Danger
- Sterilization Co. Can't Pin Cancer On Genetics, Jury Told
- Chancery Likens Claims To Recycling Losing Lottery Ticket
- Trump Demands Enforcement Of Healthcare Price Disclosures
- Kroger Seeks More Sanctions For Prolific Consumer Atty
- J&J Says Samsung Is Breaking Deal Over Stelara Biosimilar
- Insulet May Face Choice: $452M Award Or Stifling Rival
- Rethinking 'No Comment' For Clients Facing Public Crises
- Couple, Biotech Co. Jointly Drop Lost Embryos Suit
- Purdue Gets Time To Document New $7.4B Ch. 11 Settlement
- Masimo Aims To DQ Hueston Hennigan As Ex-CEO's Counsel
- Lawyer Who Became Client's 'Punching Bag' Scores Case Exit
- WilmerHale, Cleary Steer $4.1B Thermo Fisher-Solventum Deal
- Dental Co. Biolase Drills Down On Unopposed Ch. 11 Plan
- Natera's $96M DNA Test Verdict Scrapped, Patents Axed
- Fed. Circ. Shouldn't Assume Doctors Read Labels, Profs Say
- Bioanalysis Co. Worker Fired For Flagging FDA Data, Suit Says
- Biotech Minority Investor Sues In Del. To Block Control Moves
- Insurer Needn't Cover Hospital's $2.5M Virus Vax Probe Costs
- PBMs To Challenge FTC Case At 8th Circ., But Without Pause
- Purdue's New Ch. 11 Plan Sidesteps Nonconsensual Releases
- As Failure-To-Warn Preemption Wanes, Justices May Weigh In
- Boehringer Ingelheim Wins Illinois Zantac Cancer Retrial
- Skadden, Ropes & Gray Advising On 23andMe Buyout Bid
- How Design Thinking Can Help Lawyers Find Purpose In Work
- Elizabeth Holmes Loses 9th Circ. Appeal Over Theranos Fraud
- Justices Nix Whistleblower Suit Over Arbitral Vacatur Limits
- Paul Hastings Adds Boston Co-Chair For New Tech Practice
- Colo. Woman Tells Jury Sterilization Plant Caused Cancer
- WebMD Users Secure Class Certification In Video Privacy Suit
- MSN Calls Novartis' Entresto Delisting Protest 'Disingenuous'
- Eli Lilly Has Exclusivity Over Weight Loss Drug, FDA Says
- Harry Manbeck, Former USPTO Head, Dies At 98
- NFL Alums Accused Of Misusing COVID Outreach Funding
- Pharma Co. Investors Get Final OK For $3M Settlement
- The Fate Of Biden-Era Clinical Study Guidance Under Trump
- Trending At The PTAB: Insights From 2024 Fed. Circ. Statistics
- Manufacturer Not Covered For Pot Grower Claims, Court Told
- UChicago Medical Center Can't Duck Wage Suit
- Weight Loss Drug Patient Drops Appeal In Cancer Risk Suit
- Weight Drug Suits Highlight Need For Legal Work On Safety
- 10 Issues To Watch In Aerospace And Defense Contracting
- Veolia Ends One Of Few Remaining Flint Water Suits For $53M
- Paul Hastings Seeks To End GenapSys Malpractice Action
- NJ High Court Takes Up Pharma Co. Fraud Coverage Row
- WilmerHale Corporate Ace Joins DLA Piper In California
- Del. Justices' D&O Ruling Clarifies 'Related' Claim Analysis
- NIH Research Cuts Stay On Hold As Judge Mulls Objections
- Compliance Pointers For DOJ's Sweeping Data Security Rule
- DOJ Says Job Protections For ALJs Are Unconstitutional
- Trump Trans Edicts Will Cause More Teen Suicides, States Say
- Generic-Drug Group Rallies Behind Appeal In Entresto Fight
- Boston, Other Cities And MassBio Back Challenge To NIH Cuts
- Green Groups Ask 9th Circ. To Press EPA Again On Atrazine
- Feds Say DC Judge Can't Bar 'Hypothetical' Spending Freezes
- Drug Buyers Get OK On $275M Sandoz Antitrust Settlement
- Ex-Heritage Pharma CEO Disciplined Over Price-Fixing Case
- Ex-Opioid CEO's Billing Spat With Trial Atty Lands In Court
- Research Co. Liable For Bungling $52M COVID-19 Mask Deal
- Competitive Weightlifting Makes Me A Better Lawyer
- What To Know About Trump's Likely Pick For USPTO Director
- Walgreens Says $1B COVID Testing Award Must Be Nixed
- Colorado Joins Fight Against Trump Trans Health Order
- Ga. Woman Implanted With Wrong Embryo Sues Fertility Clinic
- Gilead, Janssen Settle HIV Treatment Suits With Lupin, Apotex
- COVID Fraudsters Get Prison For Trying To 'Make A Buck'
- Judge Won't Halt PBM Case Over Attack On FTC Independence
- Fla. Court Won't Revive Property Manager's COVID Claims
- 3rd Circ. Doubts Alleged Cancer Risk Devalued Drug
- LA Gardasil Trial Against Merck Bagged After 3 Weeks
- BP Must Face Contract Claim In Bayer's $12M Benzene Suit
- The Case For Compliance During The Trump Administration
- Wu-Tang Album Owner Wants Shkreli To Pay Fees
- Simpson Thacher Adds Litigator, Private Funds Pro In Boston
- 1st Circ. Backs Strict View Of Kickback Law In Blow To FCA
- Hikma Appeals To Justices In 'Skinny Label' Patent Case
- Studies Don't Show Zantac Cancer Risks, Jury Hears
- J&J Talc Unit Launches 2-Week $10B Ch. 11 Settlement Trial
- Novo Nordisk Queues Up $830M Suit Over Disappointing Drug
- Convicted Pharma Exec Seeks Trial Redo, Citing Feds' Error
- Human Rights Atty Sees 'Serious Risks' Of Neural Data Abuse
- Trump Issues Order Calling For Expanded IVF Access
- Trump Trans Order Is Unconstitutional 'End-Run,' Judge Says
- Vaccine Developer Files Ch. 11 Sale Plan With $11.5M Bid
- A Look At HHS' New Opinion On Patient Assistance Programs
- Ex-Goldman Atty Squires Expected To Be Named USPTO Head
- FTC's Ferguson, PBMs Agree: Nix Leader Removal Safeguards
- Digital Health Co. Beats Some Claims In SPAC Investor Suit
- Fed. Circ. Risks Relying On 'Science Fiction,' Justices Told
- Trump Admin To Cut Thousands Of Federal Health Employees
- New Delisting Rules Shorten Leash For Distressed Companies
- CVS Wins Arbitration In Medicare Fee Antitrust Suit
- Fed. Circ. Rejects COVID Test Suit In Gilstrap-Authored Ruling
- Some Discovery On Hold In Abbott Infant Formula Case
- Fed. Circ. Ruling Shows Even Small Cos. Can Win At ITC
- 8 Things Attys Should Know About Conn.'s $55B Budget
- Judge Upholds Pay-For-Delay Ban Law, But Only In Calif.
- Camston Wrather Files For Ch. 7 With Over $100M In Debt
- Tariffs On Drugs And Chips May Not Bring Makers Stateside
- Inconsistent Injury-In-Fact Rules Hinder Federal Practice
- 2nd Judge Blocks Trump Trans Health Order, Chides DOJ Atty
- Mallinckrodt Fails To Halt Airgas' Generic Nitric Oxide Drug
- DC Judge Affirms Approval Of Teva's Generic Sleep Drug
- Long-Term Zantac Use Raised Cancer Risks, Jury Hears
- Maryland Judge Blocks Trump's Orders On Trans Healthcare
- 2 Anti-Kickback Developments Hold Lessons For Biopharma
- Merck Investor Sues Over Gardasil China Market Projections
- In-House Counsel Pointers For Preserving Atty-Client Privilege
- 9th Circ. Upholds DEA Denial Of Psilocybin Petition
- How SDNY US Atty Nom May Shape Enforcement Priorities
- Musk's $97B OpenAI Bid Dubbed A 'Stunt' Amid Other Rumors
- Robert F. Kennedy Jr. Confirmed, Sworn In As HHS Secretary
- Paul Hastings, Cooley Lead Obesity-Focused Aardvark's IPO
- Greenberg Traurig Adds Goodwin Life Sciences Pro In Texas
- Judge Finds No Infringement In Alcon's Eye Drop Patent Suit
- Bausch Health Beats Suit Over 'Faking' Financial Stability
- Supply Co. Files Failsafe $387M Suit Amid Threat Of Dismissal
- Aurion Tells Del. Justices IPO Delayed Amid Investor Battle
- Labcorp Can't Score New Trial After $384M Patent Loss
- Paraquat Plaintiffs Urge 7th Circ. To Revive MDL Suits
- RI Judge Won't Pause Order To Unfreeze Funds Amid Appeal
- Ga. Judge Trims Untimely Paragard IUD Claims From MDL
- Boston's Opioid Damages Claims Tossed As Too Late
- Improving Comms Between Trial Attys And Tech Witnesses
- What's Next For State Regulation Of Hemp Cannabinoids
- Collecting Rare Books Makes Me A Better Lawyer
- Wash. Health Privacy Law Debuts In Amazon Tracking Suit
- Medtronic, Axonics Agree To End Bladder Control Patent Fight
- Kratom Producers Hid 'Addictive' Risks, Consumers Say
- Teva Says Mixed Coreg Rulings Undermine GSK Damages Bid
- J&J Allies Dub Milestone Fee Reversal 'Crucial' To Del.
- Novo Nordisk Mostly Escapes Insulin Pen Contamination Suit
- MSN Urges Fed. Circ. To Reinvalidate Novartis' Entresto IP
- Split 3rd Circ. Keeps Merck Vaccine Antitrust Panel Immunity
- Research Org Faces Investor Suit Over Customer Cost-Cutting
- New DOJ Leaders Should Curb Ill-Conceived Prosecutions
- A 'Disaster For Science': Universities Sue Over NIH Grant Cap
- Tips For Pharma-Biotech Overlap Reporting In New HSR Form
- CVS, Aetna Escape Testing Lab's $20.6M Unpaid Invoices Suit
- DC Judge Orders Restoration Of Public Health Webpages
- Judge Should Not Have Been Reprimanded For Alito Essay
- Novartis To Buy US Pharma Biz Anthos For Up To $3.1B
- Pharma Co. Misled Investors On Depression Drug, Suit Says
- Fed. Circ. Preserves Corning's Win In Gene Therapy Fight
- GenapSys Can't Claw Back Some Docs From Paul Hastings
- DC Judge Questions Abrupt Removal Of Public Health Info
- Fed. Circ. Revives Cotter's Radiation Injury Suit Indemnity Bid
- A Look At Drug Price Negotiation Program's Ongoing Impact
- Congress Must Consider Accurate Data About Patent Thickets
- PBMs Fight To Keep Mich. AG's Opioid Suit In Federal Court
- Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit
- Fighting Cancer Has Impaired Life, Zantac Plaintiff Testifies
- Mass. Judge Temporarily Blocks NIH Funding Cuts
- Life Sciences Group Of The Year: Fenwick
- Trump Admin Violating Order To Unfreeze Funds, Judge Says
- Lights, Camera, Ethics? TV Lawyers Tend To Set Bad Example
- Biotech Firm Omega Therapeutics Hits Ch. 11 To Restructure
- Trump Isn't Obeying Order To Unfreeze Funds, States Say
- NC Judge Knocked By Fed. Circ. For Rushing Patent Trial
- NJ Statehouse Catch-Up: Offshore Wind, AI, Neurodiversity
- 70 Depo-Provera Suits Joined In Florida's Northern District
- SPAC Market Hums Again Following Multiyear Downturn
- Fed. Circ. Backs Ventria Cell Culture Patent Win At ITC
- Fed. Circ. Considers Some Testing For Avadel Sleep Drug
- Pa. Medical Pot Co. Beats Consultant's IP Breach Claims
- Del.'s Quiet Ambition To Tweak Chancery, Stem Feared DExit
- Trump Drops High Court Opposition To Transgender Care Ban
- Life Sciences Group Of The Year: Cooley
- Taxation With Representation: Kirkland, Latham, Skadden
- Will 4th Time Be A Charm For NY's 21st Century Antitrust Act?
- Accountant-Owned Law Firms Could Blur Ethical Lines
- 3 Firms Guide Bain On $3.4B Japanese Pharma Co. Buy
- UK Litigation Roundup: Here's What You Missed In London
- Doctors Org. Wants Health Agency Website Info Restored
- Tom's 'Natural' Kids Toothpaste Has Lead, Arsenic, Dad Says
- Sterilization Plant's 'Royal' Mistake Leaked Pollution, Jury Told
- Goodwin, Ropes Lead Cystic Fibrosis Co.'s Upsized $191M IPO
- Buyers Want Kratom Cos. Addiction Suit To Go On
- CooperSurgical Hit With IVF Embryo Loss Class Claims
- Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book Row
- UnitedHealth Drops Bid To Toss Home Health Deal Challenge
- EIP Grows US Team With 2 Pranger Law Attys
- GSK's Zantac Woes Gave Investors Heartburn, Suit Says
- Globus Medical Buys Device-Maker Nevro In $250M Deal
- The Post-Macquarie Securities Fraud-By-Omission Landscape
- Life Sciences Group Of The Year: Freshfields
- Harvard Biotech Patent Case Ends With Mid-Trial Deal
- AI Will Soon Transform The E-Discovery Industrial Complex
- Sterilization Co. Skimped On Pollution Controls, Residents Say
- Colo. University Hit With Suit Over 'Culture Of Chauvinism'
- Wachtell, Skadden Guide Becton's Bid To Sell Diagnostics Biz
- Dickinson Wright Continues IP Growth With Chicago Hire
- IP, Licensing, M&A Trends To Watch In Life Sciences This Year
- Injectable Drug Device Maker West Pharma Secures Ban At ITC
- CVS Beats 2nd Investor Suit Over Omnicare Deal
- 6th Circ. Urged To Revive Allergy Co.'s Antitrust Claims
- When Innovation Overwhelms The Rule Of Law
- Life Sciences Group Of The Year: Hogan Lovells
- Activist Nominates 4 Director Candidates To Kenvue Board
- McKesson, Others Beat Indirect Drug Reseller Price-Fix Suit
- Judge Explains Biogen Class Cert. Ruling After 1st Circ. Order
- Fed. Circ. Grapples With Extensions On Reissued Patents
- Carcinogenic Risk Unknown When BI Owned Zantac, Jury Hears
- McKesson Paying $850M For Top Stake In Eye Health Co.
- Anticipating Direction Of Cosmetics Regulation Under Trump
- Drug Pricing Policy Trends To Expect In 2025 And Beyond
- 'Sloppy' Work Hurts Lab's $20.6M Insurance Suit, Judge Says
- Docs Say DEA Didn't Put All Documents In Pot Hearing Record
- Doctors Org. Sues Over Health Agency Website Purges
- Life Sciences Group Of The Year: Latham
- Imagine The Possibilities Of Openly Autistic Lawyering
- Mintz Adds Dentons West Coast Corporate Head In San Diego
- Javice's Texts About Elizabeth Holmes Not Fair Game For Trial
- Party-Line Vote Sends Kennedy's HHS Nomination To Senate
- 6th Circ. Axes $650M Judgment Against CVS, Walgreens
- Apple Seeks Bench Trial Win In Masimo's Trade Secret Suit
- DOJ Poised To Prosecute Threat-Makers Against DOGE
- Zantac's Discoloration Merely 'Cosmetic,' Boehringer Rep Says
- Allergan Tells 4th Circ. Medicaid Pricing Suit Rightly Tossed
- Baby Sock Co. Inks $3.5M Deal In Investor's FDA Approval Suit
- Pro-Palestine Protesters Say UMich Bans Trample Rights
- PharmacyChecker's Legality Weighed In 9th Circ. Appeal
- Top 10 Healthcare And Life Sciences Issues To Watch In 2025
- Parsing 3rd Circ. Ruling On Cannabis, Employee Private Suits
- 4 Keys To Litigating In An Active Regulatory Environment
- J&J Investigations And Gov't Litigation Head Joins O'Melveny
- Asbury Park, Zoning Board, Again Escape Pot Co.'s Suit
- Cystic Fibrosis Drug Developer Sionna Targets $150M IPO
- DC Judge Joins RI In Blocking Trump Funding Freeze
- Kiromic SEC Order Shows Importance Of Self-Reporting
- Documentary Filmmaking Makes Me A Better Lawyer
- Goodwin Hires Kirkland Antitrust Partner In DC